FDA Drug Application (201921) for LANSOPRAZOLE by NATCO PHARMA LTD

Back to FDA Applications sponsored by NATCO PHARMA LTD

Application Number201921
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
Dosage15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLANSOPRAZOLE
Active IngredientLANSOPRAZOLE



Back to FDA Applications sponsored by NATCO PHARMA LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.